Summary of Consolidated Financial Results(For the Third Quarter Ended December 31, 2009)
February 3, 2010
Tokyo Stock Exchange
Company name: KYORIN Co., Ltd.
Code number: 4569
Web site: http://www.kyorin-gr.co.jp/
Representative: Masahiro Yamashita, Representative Director, President and Chief Executive Officer
Contact: Yoh Ito, Executive Officer, Director, Finance & Accounting
TEL (03) 3293-3420
Scheduled date for submitting quarterly report: February 10, 2010
Scheduled date for starting dividend payment: —1. Consolidated Results for the Nine Months Ended December 31, 2009 (From April 1, 2009, to December 31, 2009)(1) Consolidated Operating Results(Percentage changes relative to previous corresponding period)
Net sales
Operating income
Ordinary income
Million yen% Million yen% Million yen%
Nine months ended
74,57912.4
11,045106.9
11,860117.6
December 31, 2009
Nine months ended
66,361
—
5,339
—
5,451
—
December 31, 2008
Net income
Nine months ended
December 31, 2009
Nine months ended
December 31, 2008

Net income per share(Diluted)

Net income per share

Million yen%YenYen

7,537

794.7

100.83—842—11.26—(2) Consolidated Financial Position
Total assets
Net assets
Million yen
Million yen
As of December 31,
133,860
103,3492009
As of March 31, 2009
124,552
96,501
Note: Equity: Nine months ended December 31, 2009: ¥103,349 million,
Fiscal year ended March 31, 2009: ¥96,501 million

Equity ratio%

Net assets per share
Yen

77.2

1,382.58

77.5

1,290.67

2. Dividends
Dividend per share(Record date)Fiscal year ended
March 31, 2009
Fiscal year ending
March 31, 2010
Fiscal year ending
March 31, 2010
(Forecast)End of the
1st quarterYenEnd of the
2nd quarter
Yen

End of the
3rd quarter
Yen

—

4.00

——

Year-end

Total

Yen

Yen

—

9.00

13.00

10.00

————

—

35.00

45.00

Note: Revisions to the dividend forecast in the current quarter: None――
13. Forecast of Consolidated Results for the Year Ending March 31, 2010
(From April 1, 2009, to March 31, 2010)(Percentage changes relative to previous corresponding period)
Net sales
Operating income
Ordinary income
Million yen% Million yen% Million yen%
Full year
99,5009.5
12,00034.0
12,80039.0
Net income

Net income per shareMillion yen%
Yen
Full year
8,100
297.6
108.35
Note: Revisions to consolidated business forecast in the current quarter: None
4. Other(1) Change in major subsidiaries during the period (Change of specified subsidiaries associated with a change of thescope of consolidation): Yes
Consolidation (Inclusion): —Excluded: 2 (Company name: Japan Medical Advance Co., Ltd. and Bistner First Investment LPS)
(2) Adoption of simplified accounting method and accounting methods specific to preparation of the quarterly
consolidated financial statements: None
(3) Change in accounting policies and procedures and presentation methods for preparation of the quarterlyconsolidated financial statements (those indicated as changes in Important Matters as a Basis for Preparation of
the Quarterly Consolidated Financial Statements)
1) Changes pursuant to revision of accounting standards, etc.: None
2) Changes other than 1): None
(4) Number of shares issued (common stock)1) Number of shares issued and outstanding at the end of the period (including treasury stock)
As of December 31, 2009: 74,947,628 shares,
As of March 31, 2009: 74,947,628 shares
2) Number of shares of treasury stock at the end of the period
As of December 31, 2009: 196,182 shares,
As of March 31, 2009: 179,456 shares
3) Averaged number of shares during the period (quarterly cumulative period)
Nine months ended December 31, 2009: 74,758,946 shares,
Nine months ended December 31, 2008: 74,799,945 shares* Explanations about the appropriate use of the business forecasts and other noteworthy points
1. These forecast performance figures are based on information currently available to the Company and may include
uncertain factors or risk that affect our future performance. Accordingly, actual business results may materiallydiffer from the forecasted figures due to various factors in the future.

――2